Pharma channel feed – Endpoints News

Pharma channel feed

Judge triples Eli Lilly's payout in Medicaid rebate case to $183M+

3 years ago

Sanofi and AstraZeneca's RSV antibody cuts hospitalizations by 83% in late-stage study, as $10B market battle heats up

3 years ago

FDA signs off on Otsuka, Lundbeck's antipsychotic for Alzheimer's agitation

3 years ago

Crushing their categories? Physicians weigh in on pharma companies by therapy area

3 years ago

House committee holds hearing to identify root causes of recent drug shortages

3 years ago

Merck triumphs in $1.4B cyberattack appeals case

3 years ago

BioCryst debuts print magazine for hereditary angioedema patients taking Orladeyo

3 years ago

AAV producer NewBiologix emerges from stealth with $50M Series A

3 years ago

Senate Finance chair slams pharma industry's use of foreign subsidiaries to cut their tax bills

3 years ago

What's 'meaningful' pharma innovation? House subcommittee talks incentives

3 years ago

Teva's new CEO Richard Francis is planning a 'new chapter' for the generics giant

3 years ago

Insulin prices in the Senate hot seat: PBM and pharma finger-pointing continues as landscape shifts

3 years ago

FDA adcomm votes unanimously in favor of benefit-risk profile of over-the-counter contraceptive Opill

3 years ago

‘Pharma Bro’ Martin Shkreli's companies file for bankruptcy

3 years ago

Stop the music: Public health advocates join fight to ban ‘distraction technique’ in drug ads

3 years ago

When orphan drugs are blockbusters: Researchers call on Congress to make companies pay back tax credits

3 years ago

AstraZeneca blockbuster Farxiga adds new heart indication to label

3 years ago

Gilead wins US patent trial over HIV prevention drugs

3 years ago

After warning letters and fatal poisonings, FDA issues guidance for stringent testing of contaminants

3 years ago

Roche, Merck and Pfizer lead US pharma corporate reputation ranking by patient groups

3 years ago

Bristol Myers Squibb lays off 48 in New Jersey

3 years ago

Abortion providers sue FDA in a Virginia federal court over mifepristone restrictions

3 years ago

MarketingRx roundup: AbbVie debuts Vraylar campaign for depression; Amylyx re-ups “Get Inked” for ALS effort

3 years ago

Tarsus issues 'call to action' months before FDA decision on eye mite treatment

3 years ago

First page Previous page 127 128 129130131 132 133 Next page Last page